Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

CliniSys

For over 30 years CliniSys Group has been at the forefront of diagnostics workflow, order communications and informat... read more Featured Products: More products

Download Mobile App




New Collaboration Integrates Low-Code Automation into Laboratory Platform

By LabMedica International staff writers
Posted on 03 Aug 2026

Clinical laboratories face rising operational complexity, regulatory scrutiny, and pressure to deliver faster results. More...

Traditional LIMS and LIS configurations often depend on scarce development resources, creating delays and limiting agility. To adapt more efficiently, organizations need governed ways to redesign workflows without rewriting code. A new system now embeds low-code/no-code capabilities within a laboratory platform, helping teams modify workflows quickly while maintaining control and regulatory confidence.

Clinisys (Tucson, AZ, USA) has formed a strategic partnership with Decisions (Virginia Beach, VA, USA), integrating Decisions’ low-code/no-code orchestration, automation, and advanced AI capabilities into the Clinisys Platform. The collaboration is positioned as a scalable alternative to conventional configuration models, aiming to accelerate time-to-value while preserving operational control and regulatory assurance. The combined approach is intended to let laboratories adapt LIMS/LIS configurations more efficiently without compromising governance.

At the core of the integration is a low-code/no-code engine that enables laboratories to design, adapt, and manage workflows using visual tools and reusable components. Decisions adds a unified environment for workflow automation, rules management, and integration so organizations can orchestrate complex processes without writing code. By embedding these capabilities directly into the platform, teams can modify and optimize workflows within a structured, controlled framework rather than relying on proprietary languages or vendor-restricted development tools.

The companies indicate the model supports implementation and system changes, reduces dependency on custom development and specialized expertise, and supports regulatory compliance and traceability. It is designed to scale workflows as testing requirements evolve across healthcare, life sciences, public health, environmental testing, food and beverage, toxicology, and manufacturing. The partnership promotes laboratory-controlled configuration so systems can evolve with operational needs while remaining structured, auditable, and traceable.

“Laboratories don’t need more features; they need flexible ways to adapt workflows as their operational requirements evolve beyond traditional, code-heavy paradigms. This partnership puts configuration control and advanced AI tools into the hands of the laboratory, enabling teams to design and adjust workflows through visual tools while maintaining the structure, governance, and performance they require,” said Shay Hassidim, Chief Technology Officer, Clinisys.

“Laboratories are managing increasingly complex, rules-driven processes and those processes need to evolve alongside the science itself. By bringing together Clinisys’s laboratory expertise with our orchestration and rules platform, we’re enabling organizations to adapt workflows more efficiently while keeping decision logic clear, consistent, and scalable,” said Giles Whiting, CEO, Decisions.

Related Links
Clinisys
Decisions


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.